Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Phentermine recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Phentermine (19 total). Check the affected lots below.

Most common reason: cGMP deviation (10 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Phentermine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Phentermine recalls on record

none so far in 2026; 19 on record, newest first
Class II · Moderate risk

Phentermine

cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.

Terminated Stability / shelf life Calvin Scott & Company, Inc. NDC 00527-0597-10 D-0011-2021
Class II · Moderate risk

Phentermine HCL Blue Speckled tablets

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 10702-0025-10 D-1532-2020
Class II · Moderate risk

Phentermine HCL Blue/White Capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 10702-0029-10 D-1529-2020
Class II · Moderate risk

Phentermine HCL Blue/Clear capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 10702-0028-10 D-1528-2020
Class II · Moderate risk

Phentermine HCL Yellow Caps 30mg

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 51224-0202-70 D-1527-2020
Class II · Moderate risk

Phentermine HCL GrayYellow capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 51224-0203-70 D-1526-2020
Class II · Moderate risk

Phentermine 15mg grey/Yellow Capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 11534-0157-03 D-1525-2020
Class II · Moderate risk

Phentermine HCL Gray/Yellow capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 10702-0026-10 D-1524-2020
Class II · Moderate risk

Phentermine Hydrochloride Capsules

CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed

Terminated Packaging defect Aurobindo Pharma USA Inc. NDC 13107-105-01 D-1236-2020
Class III · Low risk

Phentermine

Failed Impurities/Degradation Specification; out-of-specification results for individual unknown impurities at the 30 month Room Temperature Retained Sample stability test

Terminated Temperature excursion Aidarex Pharmaceuticals LLC D-1162-2017
Class III · Low risk

Phentermine Capsules

Failed Impurities/Degradation Specifications:Out of specification results for individual unknown impurities at 30th month Room Temperature Retained Sample stabilities test .

Terminated Impurity / degradation PD-Rx Pharmaceuticals, Inc. NDC 55289-791-07 D-1118-2017
Class III · Low risk

Phentermine HCL Capsules

Failed Impurities/Degradation Specifications: out-of-specification results obtained for individual unknown impurities found at 30 month Room Temperature Retained Sample stability test.

Terminated Impurity / degradation KVK-Tech, Inc. NDC 10702-026-01 D-1083-2017
Class III · Low risk

Phentermine Hydrochloride Capsules

Failed impurities/Degradation specifications: out of specification results for individual unknown and total impurity at the 12th month room temperature stability test station

Terminated Impurity / degradation PD-Rx Pharmaceuticals, Inc. NDC 55289-791-07 D-0574-2016
Class III · Low risk

Phentermine Hydrochloride Capsules

Failed Impurities/Degradation Specifications: out-of-specification results for individual unknown and total impurity at the 12th month room temperature stability test station

Terminated Impurity / degradation KVK-Tech, Inc. NDC 10702-0026-01 D-1371-2015